↓ Skip to main content

Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey

Overview of attention for article published in BMC Cancer, April 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey
Published in
BMC Cancer, April 2012
DOI 10.1186/1471-2407-12-152
Pubmed ID
Authors

Yuko Kodama, Ryoko Morozumi, Tomoko Matsumura, Yukiko Kishi, Naoko Murashige, Yuji Tanaka, Morihito Takita, Nobuyo Hatanaka, Eiji Kusumi, Masahiro Kami, Akihiko Matsui

Abstract

The financial burden of medical expenses has been increasing for cancer patients. We investigated the relationship between household income and financial burden among patients with chronic myelogenous leukaemia (CML) who have been treated with imatinib.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 4%
Bangladesh 1 2%
Unknown 43 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 24%
Student > Master 6 13%
Student > Bachelor 5 11%
Student > Postgraduate 3 7%
Other 3 7%
Other 7 15%
Unknown 11 24%
Readers by discipline Count As %
Medicine and Dentistry 18 39%
Nursing and Health Professions 4 9%
Agricultural and Biological Sciences 3 7%
Business, Management and Accounting 2 4%
Psychology 2 4%
Other 6 13%
Unknown 11 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 December 2012.
All research outputs
#14,615,032
of 22,691,736 outputs
Outputs from BMC Cancer
#3,616
of 8,250 outputs
Outputs of similar age
#100,105
of 163,209 outputs
Outputs of similar age from BMC Cancer
#35
of 72 outputs
Altmetric has tracked 22,691,736 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,250 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,209 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.